decorative background image

ZERO Ranked Top Nonprofit to Work For

NPT's Best Nonprofit to work for 2017

By The Nonprofit Times’ “Best Nonprofits to Work For”

Washington, D.C. – Dogs underneath desks, jeans day every day of the week, and an unrivaled passion for ending prostate cancer. What do these three things have in common? You can find them all at ZERO Prostate Cancer.

As the highest-ranking cancer charity by The Nonprofit Times’  “Top 50 Best Nonprofits to Work For”, ZERO was the number 10 overall organization on the list. ZERO’s position on the list jumped 10 spots this year, the number three ranked among all small nonprofits. This is the fourth consecutive year for ZERO to be recognized on the list.

There are no typical days at ZERO, and we’re proud of that. ZERO team members work hard to put passion into action to help men and families impacted by prostate cancer. They provide critical patient support programs, fight to protect research funding, and educate men on risk factors. While ZERO’s environment is casual and pet-friendly, ZERO employees are serious about saving lives.

“Our team members are selfless in their dedication to our mission to end prostate cancer,” said ZERO CEO Jamie Bearse. “I'm proud and honored to work alongside such talented team players in a steadfast commitment to saving lives from this disease.”

Creating a quality workplace is a consistent priority for ZERO. ZERO rewards employees with a culture that values career and personal growth, creativity, and work-life balance. Team members champion transparency and courage as part of the organization’s core values. With continued growth, ZERO remains laser focused on impact and making a difference for men and their families.

For the past 20 years, ZERO has worked on behalf of all men affected by prostate cancer and their families through advocacy for increased research funding, community awareness events, financial assistance, and patient support programs. Earlier this year that hard work paid off. For the first time in over a decade, Congress proposed an increased budget for the Prostate Cancer Research Program (PCRP) at the Department of Defense allocating an additional $10 million for FY17. PCRP funding for prostate cancer research has already led to three new, life-saving drugs and a new diagnostic screening tool.